A cDNA clone encoding a neural-specific putative protein-tyrosine-phosphatase (protein-tyrosinephosphate phosphohydrolase, EC 3.1.3.48) has been isolated from a rat striatal eDNA library. The deduced amino acid sequence predicts a protein of -369 amino acids with a ftreng homology to other members of the family of protein-tyrosinephosphatases. In vitro trauslatlon produces a protein with an apparent molecular mass of 46 kDa. A potential attachment mechanism to the cytoplasm membrane is suggested by a myristoylation amino acid-consensus sequence at the N terminus ofthe protein. RNA analyses of various regions ofrat brain reveal a 3-kilobase (kb) and a 4.4-kb mRNA. The 3-kb mRNA is highly enriched within the striatu relative to other brain areas and has been termed a "striatum enrichedphosphatase" (STEP). In contrast, the 4.4-kb message is most abundant in the cerebral cortex and rare in the striatum. These two messages appear to be alternatively processed RNA transcripts of a single gene.
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It is well established that modulation of tyrosine phosphorylation is one mechanism for controlling cellular proliferation and differentiation (1) . The addition and removal of phosphate groups on tyrosine residues is thought to be tightly controlled by the opposing actions of protein-tyrosine kinases and protein-tyrosine-phosphatases (protein-tyrosinephosphate phosphohydrolase, EC 3.1.3.48; PTPases) (for recent review, see ref.
2). Until recently, research has concentrated on the role of protein-tyrosine kinases in cellular control mechanisms.
Originally, phosphatases were viewed as a small group of enzymes with a rather broad substrate specificity. The recent isolation of a number of PTPases suggests that this may not be correct. PTPases were first identified when the human placental PTPase 1B was isolated, purified, and shown to be homologous to a repeated sequence in the cytoplasmic domain of the leukocyte cell-surface protein CD45 (also known as leukocyte common antigen, or LCA) (3) . Although the function of CD45 was not known, the fact that CD45 and PTPase 1B were homologous suggested that in lymphocytes, CD45 might regulate the state of phosphorylation of a group of substrate proteins. Subsequent experiments confirmed that PTPases dephosphorylate tyrosine residues, with little or no effect on serine/threonine residues (4, 5) .
Since the initial report on PTPase 1B, a number ofPTPases have been cloned and their amino acid sequences determined. Two basic variants have emerged. Those (6) (7) (8) (9) (10) (11) . PTPases in the second class are located intracellularly and lack a transmembrane or extracellular domain. Several have been isolated and characterized as well (5, 12, 13 (14) . However, none of the PTPases identified to date have been shown to be nervous system specific.
Here, we report the isolation and characterization of a cDNA clone that encodes for a putative PTPase found predominantly in the brain.1 Within the brain, this PTPase shows further tissue specificity by appearing to be a "striatum enriched phosphatase" and has been designated STEP. This PTPase contains regions homologous to ones found in previously characterized PTPases and appears to be a distinct member of the cytoplasmic class of PTPases.
MATERIALS AND METHODS RNA Isdation. Total RNA from bovine putamen was isolated by using a modification (15) of the guanidinium isothiocyanate procedure of Glisin et al. (16) . For library construction, poly(A)+ RNA was twice selected by affinity chromatography using oligo(dT)-cellulose (17 (20, 21) , followed by S1 nuclease digestion (21) and C-tailing (22) . The plasmid pUC-9 (Stratagene) was linearized at its Pst I site and G-tailed to allow hybridizing to C-tailed cDNA.
Abbreviations: PTPase, protein-tyrosine-phosphatase; STEP, striatum enriched phosphatase.
Neurobiology: Lombroso et al. 18 hr, followed by washes in 0.5x SSC/0.1% SDS at 650C. EcoRI inserts of purified clones were subcloned into the plasmid vector Bluescript (Stratagene), and DNA was purified by CsCl ultracentrifugation (24) .
DNA Sequence Analysis. Nucleotide sequences were obtained using the chain-termination methods of Sanger (25) after either subcloning inserts into M13 bacteriophage or by using cDNA clones in Bluescript, which were progressively digested using Exo 
RESULTS
Isolation and Characterization of STEP cDNA Clones. A putamen-enriched plasmid cDNA library was constructed from bovine tissue. Over 90%6 contained inserts with an average size of300 nucleotides, and 10%6 ofthese represented mRNAs that were enriched in the putamen relative to cerebellum (data not shown). One of these clones containing a 300-bp insert was used to screen a rat striatal Agtll library. The initial screen yielded a 1-kb cDNA clone (9.2) containing portions of an open reading frame (see Fig. 5 for all clones isolated). The 5' region was used to rescreen Agtll libraries to obtain overlapping clones encoding a complete open reading frame. The sequence obtained from these overlap ping cDNA clones is shown in Fig. 1 Fig.  1 (12) . A comparison of the predicted amino acid sequence of STEP with the previously described intracellular PTPases, T-cell PTPase and placental PTPase iB, reveals --30%o identity. The degree of similarity 'increased to >50% by allowing conservative substitutions. As illustrated in Fig. 2 cated near the C terminus of STEP, in the other cytosolic PTPases described to date it is closer to the N terminus.
The overlapping striatal cDNA clones account for 2816 bases of coding and noncoding sequence including the poly(A) addition signal (see Fig. 1 ). A putative polyadenylylation signal, AATAAA, was found at nucleotide 2794 and was followed after 17 additional nucleotides by a poly(A)+ tail of 60 adenosine residues.
The predicted size of the STEP protein is between 38 and 42 kDa. There are three methionines at the 5' end of the open reading frame (underlined in Fig. 1 ). The first of these potential initiator codons predicts a 369-amino acid protein with an approximate molecular mass of 42 kDa. The nucleotide sequence surrounding the third methionine, however, gives a better match with the Kozak sequence for eukaryotic initiation sites (RCCAUGG) (27) . This third potential initiator methionine predicts a 329-amino acid protein of 38 kDa. To gain insight into which of these methionines could act as the initiation codon, in vitro RNA transcripts were translated by using a rabbit reticulocyte translation system. A nearly full-length fusion cDNA under the control ofa T3 polymerase promoter was constructed (clone 9.6). Fig. 3 shows that the resultant RNA transcripts direct the synthesis of a single prominent protein with an apparent molecular mass of 46 kDa. A few minor smaller proteins were seen with prolonged exposure. Although these results are most consistent with the use of the first potential initiator methionine, PAGE may not be sensitive enough to distinguish between the three sites accurately. Generation of antisera will be required to determine the actual size of STEP protein in vivo (see Discussion).
Expression of STEP mRNA. The initial nucleic acidsubtraction strategy used to isolate STEP was designed to identify gene products enriched in striatum. Fig. 4a demonstrates that STEP is selectively expressed in the nervous system. Whole-brain RNA contains a predominant 3-kb mRNA species and a second 4.4-kb species that is more distinct on longer gels when probed with the 400-bp 3' fragment (Fig. 4A, Right and adrenal, kidney, and heart. The ratio of band intensities demonstrates that STEP mRNA is much more abundant in brain relative to peripheral tissues. The distribution of STEP mRNA within the central nervous system is shown in Fig. 4b . The 3-kb species is highly expressed in the striatum. In contrast, the 4.4-kb species appears to be expressed selectively outside the striatum. The 3-kb mRNA is also present in other brain regions but at lower levels of expression. As expected from the initial subtraction strategy, neither RNA message is present in the cerebellum.
A Southern blot of rat genomic DNA is shown in Fig. 5 . Multiple genomic fragments are present with two restriction enzymes (HindIII and Xba I), which do not cut the STEP cDNA, and with BamHI, which has a single internal site (see Fig. 5 for a restriction map) . The STEP gene thus consists of several exons distributed over at least 15 kb of genomic DNA.
DISCUSSION
The identification of STEP as a PTPase is based on its high homology to the core amino acid sequence found in other PTPases isolated to date, but specific phosphatase activity has not yet been demonstrated. Although a number of other PTPases are expressed both in peripheral tissues and in brain, STEP is the only one to be highly expressed in the nervous system. Northern analyses reveal that the intracellular phosphatases PTPase 1 and T-cell PTPase are expressed in brain. PTPase 1 mRNA shows a higher level of expression in lymphoid tissue (spleen) relative to brain and is present in liver and kidney (5) . T-cell PTPase is more abundant in spleen, thymus, and placenta relative to brain (13) . Several PTPases with transmembrane and extracellular domains have also been isolated from brain cDNA libraries, although these proteins are expressed by a variety of tissues (9, 10) . In addition, biochemical fractionation reveals seven distinct types of PTPase activity, although none have been shown to be brain specific (28) .
Our results demonstrate that STEP expression is restricted primarily to the nervous system. The small amounts of transcripts present in peripheral tissues may actually be localized to postganglionic autonomic neurons present in peripheral tissues, and immunocytochemical staining will be used in future studies to clarify this issue. Northern analysis of brain poly(A)+ RNA reveals two distinct signals at =3 kb and 4.4 kb. The smaller band represents the mRNA that encodes STEP. This mRNA is present in the striatum and, in lesser amounts, in the cortex and midbrain regions. In contrast, the 4.4-kb message is present in all brain areas in which the lower band is found except for the striatum, where it is not visible. Neither band is present in the cerebellum; this observation is not surprising because cerebellar mRNA was used as driver in the original subtractive hybridization procedures. The absence of STEP within the cerebellum also suggests that the cerebellum may express different or unique phosphatase(s). This hypothesis is further supported by the findings that the rat brain contains high levels of tyrosinespecific protein kinase activity in a regional distribution. Interestingly, the cerebellum demonstrated one ofthe highest level of protein-tyrosine kinase activity (29) , further suggesting the possibility of cerebellum-specific PTPases.
Several lines ofevidence strongly suggest that the 3-kb and 4.4-kb poly(A)+ species are alternatively processed RNA transcripts derived from a single gene. (i) The same pattern of bands was obtained on a Northern (RNA) blot when probes were used that were a nearly full-length cDNA clone or one encompassing a region from the 3' noncoding region.
(ii) This observation is also supported by the results shown in Fig. 4 , in which the relative abundance of the two species of RNA on Northern blots is approximately equal when probed with cDNA sequence complementary to the 3' region. In contrast, the 3-kb RNA species appeared more abundant when the blots were probed with the nearly full-length STEP cDNA (Fig. 4a) . (iii) In addition, Southern blots revealed two bands when rat genomic DNA was digested with EcoRI and probed with the nearly full-length cDNA clone. This pattern is consistent with the single EcoRI restriction site that exists within the open reading frame of the 3-kb message. More detailed direct characterization of the gene structure is necessary to define the precise relationship between the 3-kb and 4.4-kb species and to rule out the alternative possibility that adjacent, duplicated genes encode the two mRNAs.
The striatal STEP transcript generated an in vitro translation product with a 46-kDa apparent molecular mass. A 369-amino acid protein is predicted if the first methionine were used as the initiator codon. Kozak consensus rules predict, however, that the third methionine of the open reading frame should be a better initiator codon, and this would produce a protein of 329 amino acids. The resulting polypeptide would have a potential N-terminal myristoylation site similar to those described for other proteins (30) . In this situation, the initiating methionine residue is removed, and the a amino group of the N-terminal glycine is modified by the covalent attachment of a myristoyl group. A similar modification has been described for a number of other proteins, including the tyrosine kinases pp60vsrc (31) serine/threonine protein phosphatase, calcineurin (32) . Although myristoylation could be the mechanism for membrane attachment of STEP, this hypothesis will need to be tested by the addition of radiolabeled myristoyl groups in the appropriate translation system. Polyisoprenylation or palmitoylation at the C terminus of the cytoplasmic PTPases has been reported as an alternative mechanism (5) . Both mechanisms would allow for the association of these enzymes with their substrates through the preexisting assembly of component parts in the form of complexes. A similar complex has been suggested for the epidermal growth factor receptor, a tyrosine kinase that forms a complex with one of its substrates, phospholipase C-y (33).
In conclusion, STEP is a protein containing sequence with a high degree of homology to the core phosphatase region found within other PTPases and which shows enrichment within the brain and a high degree of specificity within the striatum. A number of phosphoproteins are known to be enriched within the striatum (34) , including the dopamine and cAMP-regulated phosphoprotein DARPP-32 (35) . DARPP-32 itself is probably not a substrate for STEP, as it is phosphorylated on serine and threonine residues (34) . The identification of STEP will now potentially allow us to determine whether there are other striatal-specific phosphoproteins that might serve as substrate(s) for STEP. It seems likely that future studies will reveal other PTPases with patterns of nervous system expression distinct from STEP. This degree of PTPase heterogeneity in the central nervous system could provide an important mechanism for the regional control of events, such as cell division and differentiation.
